Dexamethasone Compared With Dexmedetomidine as an Adjuvant to Ropivacaine for Supraclavicular Brachial Plexus Block
Status:
Completed
Trial end date:
2018-09-01
Target enrollment:
Participant gender:
Summary
The investigators want to compare the effectiveness of dexamethasone and dexmedetomidine as
an adjuvant to 0.5% ropivacaine for supraclavicular brachial plexus block on the onset of
block and duration of analgesia, so that the investigators can choose the better adjuvant for
the investigators routine practice of regional anesthesia.